|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000168268 |
Summary for NT5DC2 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000168268 | Gene symbol | NT5DC2 |
| Gene name | 5'-nucleotidase domain containing 2 | |
| HGNC | 25717 | |
| Entrez ID | 64943 | |
| Gene type | protein_coding | |
| Synonyms | NT5DC2|FLJ12442 | |
| UniProtAcc | Q9H857 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for NT5DC2 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| NT5DC2 | 5.66e+03 | 1.13e+00 | 2.96e-01 | 3.82e+00 | 1.32e-04 | 5.67e-04 | BLCA |
| NT5DC2 | 1.40e+03 | 2.37e+00 | 3.73e-01 | 6.34e+00 | 2.29e-10 | 3.69e-09 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| NT5DC2 | 3.88e+03 | 1.06e+00 | 1.91e-01 | 5.58e+00 | 2.42e-08 | 1.25e-07 | LUSC |
| NT5DC2 | 3.08e+03 | 1.98e+00 | 3.87e-01 | 5.11e+00 | 3.24e-07 | 3.28e-06 | READ |
Top |
Sex-biased somatic mutation for NT5DC2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for NT5DC2 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg18337363 | chr3:52535037 | CGI:chr3:52532993-52534791 | UTR,promoter,exon,gene body | 5.44e-01 | 7.51e-01 | -2.64e+00 | 8.23e-03 | 1.19e-02 | -2.08e-01 |
| LUSC | cg08365687 | chr3:52535131 | CGI:chr3:52532993-52534791 | promoter | 6.83e-01 | 8.10e-01 | -2.30e+00 | 2.15e-02 | 2.53e-02 | -1.27e-01 |
| BLCA | cg13284614 | chr3:52535153 | CGI:chr3:52532993-52534791 | promoter | 4.13e-01 | 5.46e-01 | -2.09e+00 | 3.65e-02 | 3.91e-02 | -1.33e-01 |
| BLCA | cg08365687 | chr3:52535131 | CGI:chr3:52532993-52534791 | promoter | 5.18e-01 | 6.76e-01 | -2.65e+00 | 8.12e-03 | 1.20e-02 | -1.58e-01 |
| BLCA | cg00317010 | chr3:52535736 | CGI:chr3:52536346-52536826 | promoter | 7.79e-01 | 9.17e-01 | -4.58e+00 | 4.73e-06 | 7.10e-05 | -1.38e-01 |
| KIRP | cg02231066 | chr3:52533114 | CGI:chr3:52532993-52534791 | promoter,gene body | 1.36e-01 | 2.85e-01 | -4.13e+00 | 3.55e-05 | 1.08e-04 | -1.49e-01 |
| CHOL | cg02231066 | chr3:52533114 | CGI:chr3:52532993-52534791 | promoter,gene body | 1.26e-01 | 5.91e-01 | -3.10e+00 | 1.96e-03 | 1.07e-02 | -4.65e-01 |
| CHOL | cg17372223 | chr3:52534202 | CGI:chr3:52532993-52534791 | promoter,gene body | 1.14e-01 | 3.33e-01 | -3.10e+00 | 1.96e-03 | 1.07e-02 | -2.19e-01 |
| CHOL | cg18337363 | chr3:52535037 | CGI:chr3:52532993-52534791 | UTR,promoter,exon,gene body | 7.69e-01 | 8.97e-01 | -1.99e+00 | 4.65e-02 | 4.65e-02 | -1.29e-01 |
| CHOL | cg16977858 | chr3:52533494 | CGI:chr3:52532993-52534791 | promoter,gene body | 6.74e-02 | 3.22e-01 | -3.54e+00 | 4.02e-04 | 8.32e-03 | -2.54e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg05564831 | chr3:52534307 | CGI:chr3:52532993-52534791 | promoter,exon,gene body | 4.35e-01 | 2.67e-01 | 7.89e+00 | 2.95e-15 | 1.09e-14 | 1.68e-01 |
| KIRC | cg18337363 | chr3:52535037 | CGI:chr3:52532993-52534791 | UTR,promoter,exon,gene body | 8.24e-01 | 6.88e-01 | 3.03e+00 | 2.48e-03 | 7.26e-03 | 1.36e-01 |
| HNSC | cg25934064 | chr3:52535010 | CGI:chr3:52532993-52534791 | UTR,promoter,exon,gene body | 4.92e-01 | 3.70e-01 | 2.86e+00 | 4.22e-03 | 1.24e-02 | 1.22e-01 |
| HNSC | cg08365687 | chr3:52535131 | CGI:chr3:52532993-52534791 | promoter | 7.01e-01 | 5.06e-01 | 2.67e+00 | 7.60e-03 | 1.62e-02 | 1.96e-01 |
| COAD | cg25934064 | chr3:52535010 | CGI:chr3:52532993-52534791 | UTR,promoter,exon,gene body | 4.59e-01 | 5.92e-01 | -3.79e+00 | 1.54e-04 | 8.53e-04 | -1.34e-01 |
| LIHC | cg25934064 | chr3:52535010 | CGI:chr3:52532993-52534791 | UTR,promoter,exon,gene body | 6.83e-01 | 7.91e-01 | -4.18e+00 | 2.94e-05 | 1.53e-04 | -1.08e-01 |
Top |
Exon skipping events with PSI in TCGA for NT5DC2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| BLCA | exon_skip_384842 | 6.55e-01 | 7.62e-01 | -3.01e+00 | 2.60e-03 | 9.68e-03 | -1.07e-01 |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for NT5DC2 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for NT5DC2 |
TFs related to NT5DC2.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
NT5DC2 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for NT5DC2 |
RBPs related to ES in NT5DC2.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
NT5DC2 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs17059503 | chr3:58618734:G:C | - | 0.168834373370244 | 0.0346462334196209 | LIHC | Female-baised eQTL |
| rs77340367 | chr3:57767780:G:A | - | 0.133040432900992 | 0.0403623842168794 | LIHC | Female-baised eQTL |
| rs113858024 | chr3:57775192:T:C | - | 0.133040432900992 | 0.0403623842168794 | LIHC | Female-baised eQTL |
| rs78568209 | chr3:57779494:G:C | - | 0.133040432900992 | 0.0403623842168794 | LIHC | Female-baised eQTL |
| rs34529112 | chr3:57781467:C:T | - | 0.133040432900992 | 0.0403623842168794 | LIHC | Female-baised eQTL |
| rs78862612 | chr3:57781894:A:G | - | 0.133040432900992 | 0.0403623842168794 | LIHC | Female-baised eQTL |
| rs6779436 | chr3:57829857:G:A | - | 0.13143535404868 | 0.0472707604333573 | LIHC | Female-baised eQTL |
| rs79810718 | chr3:57830425:C:T | - | 0.13143535404868 | 0.0472707604333573 | LIHC | Female-baised eQTL |
| rs6779308 | chr3:57833391:A:G | - | 0.13143535404868 | 0.0472707604333573 | LIHC | Female-baised eQTL |
| rs986687 | chr3:60671241:G:T | - | -0.103314235142591 | 0.0135353543852827 | KIRC | Female-baised eQTL |
| rs13095170 | chr3:58241019:C:T | - | 0.0969665083582266 | 0.0171614417014597 | KIRC | Female-baised eQTL |
| rs112871524 | chr3:61999138:T:C | - | 0.0935970440947338 | 0.0227909859133824 | KIRC | Female-baised eQTL |
| rs1735439 | chr3:60672304:T:C | - | -0.101278637858853 | 0.0246495289103361 | KIRC | Female-baised eQTL |
| rs6774688 | chr3:62000823:G:A | - | 0.092783607951034 | 0.0255218351164649 | KIRC | Female-baised eQTL |
| rs77144467 | chr3:44062379:A:T | - | 0.0621694303947853 | 0.0381475595188223 | KIRC | Female-baised eQTL |
| rs6764188 | chr3:57097501:A:C | - | -0.0634399983260524 | 0.00335925219380844 | LUAD | Female-baised eQTL |
| rs6809523 | chr3:57099110:G:A | - | -0.0621936406103764 | 0.00428454644006612 | LUAD | Female-baised eQTL |
| rs6780995 | chr3:57104391:G:A | - | -0.0611839683978663 | 0.00440010363998728 | LUAD | Female-baised eQTL |
| rs4679647 | chr3:60214220:G:C | - | 0.0893399672802675 | 0.00444314789271011 | LUAD | Female-baised eQTL |
| rs13086176 | chr3:57100218:C:T | - | -0.0587153064179513 | 0.00571441537640833 | LUAD | Female-baised eQTL |
| rs1463657 | chr3:57103433:C:A | - | -0.0573471134227163 | 0.00894067587655466 | LUAD | Female-baised eQTL |
| rs1472369 | chr3:60228639:A:G | - | 0.0661409521110545 | 0.0160142352180618 | LUAD | Female-baised eQTL |
| rs4681953 | chr3:57107462:A:C | - | -0.0580387446925494 | 0.0181055524246534 | LUAD | Female-baised eQTL |
| rs3774667 | chr3:45633416:A:G | - | 0.0812959983662361 | 0.0190746061718009 | LUAD | Female-baised eQTL |
| rs3796362 | chr3:45632895:C:T | - | 0.0809867289981369 | 0.0198579800946821 | LUAD | Female-baised eQTL |
| rs6776722 | chr3:57108631:G:A | - | -0.053065486885062 | 0.0241234911096841 | LUAD | Female-baised eQTL |
| rs11916303 | chr3:57114940:C:A | - | -0.053065486885062 | 0.0241234911096841 | LUAD | Female-baised eQTL |
| rs6445856 | chr3:57109967:A:G | - | -0.0524418168560945 | 0.0276259585982965 | LUAD | Female-baised eQTL |
| rs9810084 | chr3:60227479:T:C | - | 0.0708322035912974 | 0.0340406510024008 | LUAD | Female-baised eQTL |
| rs9823838 | chr3:60221468:A:G | - | 0.0696865043767573 | 0.0360039882453909 | LUAD | Female-baised eQTL |
| rs9827643 | chr3:60227573:A:C | - | 0.0681721539897291 | 0.0390601218024267 | LUAD | Female-baised eQTL |
| rs1872946 | chr3:57115201:C:T | - | -0.0520239263060959 | 0.0438721996902042 | LUAD | Female-baised eQTL |
| rs1872945 | chr3:57115397:T:A | - | -0.0520239263060959 | 0.0438721996902042 | LUAD | Female-baised eQTL |
| rs12487790 | chr3:57115631:C:T | - | -0.0520239263060959 | 0.0438721996902042 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs9854395 | chr3:47545024:G:A | - | 0.0762641756216092 | 0.0205281741050392 | STAD | Male-baised eQTL |
| rs12490869 | chr3:61335225:T:C | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs17651473 | chr3:61335364:T:C | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs17651497 | chr3:61335480:C:G | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs17651515 | chr3:61335583:C:G | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs62269883 | chr3:61336029:C:A | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs77303410 | chr3:61336535:A:G | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs62269884 | chr3:61336662:A:G | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs62269885 | chr3:61336756:T:C | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs1453752 | chr3:61337219:G:A | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs12495764 | chr3:61337457:A:C | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs12495765 | chr3:61337458:A:C | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs78083246 | chr3:61337621:C:T | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs76187166 | chr3:61337679:A:T | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs12493557 | chr3:61338049:T:C | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs12490151 | chr3:61338104:C:T | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs12493577 | chr3:61338110:T:C | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs12496622 | chr3:61338353:A:T | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs76665973 | chr3:61338441:C:T | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs74901722 | chr3:61338470:T:C | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs62269886 | chr3:61338561:G:A | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs62269887 | chr3:61338764:A:G | - | 0.12957078206239 | 0.00131142882788899 | LGG | Male-baised eQTL |
| rs62269893 | chr3:61360359:C:T | - | 0.123484920501462 | 0.00278406641762153 | LGG | Male-baised eQTL |
| rs17697323 | chr3:61360413:G:C | - | 0.123484920501462 | 0.00278406641762153 | LGG | Male-baised eQTL |
| rs62268446 | chr3:61302278:T:C | - | 0.123270423915122 | 0.00281618102341339 | LGG | Male-baised eQTL |
| rs75354434 | chr3:61364022:A:G | - | 0.115052003589802 | 0.00639568052606413 | LGG | Male-baised eQTL |
| rs4688479 | chr3:61362644:G:C | - | 0.114058932515654 | 0.00734246186651904 | LGG | Male-baised eQTL |
| rs17059602 | chr3:58656725:A:G | - | 0.0421369739413565 | 0.0263151341032734 | KIRC | Male-baised eQTL |
| rs59026856 | chr3:58658635:C:G | - | 0.0420519937734014 | 0.0265666334888779 | KIRC | Male-baised eQTL |
| rs17059610 | chr3:58657443:G:A | - | 0.0415987100584384 | 0.0295358116349987 | KIRC | Male-baised eQTL |
| rs17031477 | chr3:58667016:A:G | - | 0.0408315046814159 | 0.0340090770237242 | KIRC | Male-baised eQTL |
| rs11130633 | chr3:58385065:T:C | - | -0.0544447507222784 | 0.0282170580775462 | LUAD | Male-baised eQTL |
| rs4542996 | chr3:43829602:G:T | - | -0.0522087212800292 | 0.0465789469585288 | COAD | Male-baised eQTL |
| rs17053673 | chr3:54033010:C:T | - | 0.0606360033402753 | 0.0470178646173334 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Gene ID: ENSG00000168268 | |
| CpG Site: cg25934064 | |
| Position to Gene: gene,exon,promoter,UTR | |
| Male Effect: -0.351623038425011 | |
| Female Effect: - |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg25934064 | chr3:52535010 | gene,exon,promoter,UTR | -0.351623038425011 | 8.94421923278925e-05 | -0.33814619861044154 | 9.128821938046768e-07 | KIRP |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of NT5DC2 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |